Cytomedix Allows Global Pharma Company Exclusivity to Chronic Wound Healing Technology
Cytomedix announced the implementation of a letter agreement allowing an undisclosed global pharmaceutical company an exclusivity period.
Cytomedix announced the implementation of a letter agreement allowing an undisclosed global pharmaceutical company an exclusivity period.
NWL seeks to prevent degeneration and restore function in damaged tissue, particularly in the nervous system.
NeoStem is an innovator and leader in the pre-disease collection, processing and long-term storage of adult stem cells for the general population to use in future medical applications.
Derma Sciences, a developer of wound care products, announced that its Bioguard Barrier Dressings effectively safeguarded against the H1N1 “swine flu” virus in an independent laboratory study.
Copyright © 2024 | WordPress Theme by MH Themes